The present study was aimed to evaluate the efficacy of anthelmintic agents against intestinal nematodes found in European bison. It was performed between October 2016 and May 2017, using Egg Hatch Assay (EHA) and Larval Development Assay (LDA). The parasites were obtained from faecal samples, harvested from bisons in Romania and Sweden. The efficacy of albendazole (ABZ), mebendazole (MBZ) thiabendazole (TBZ) and pyrantel (PYR) was tested. In EHA, the maximum efficacy was observed in MBZ (EC 50 = -0.227 µg/ml), and then TBZ (EC 50 = -0.2228). ABZ had a weaker result, EC 50 being 0.326 µg/ml. All tested benzimidazoles registered hatching percentages below 50%, reflecting the lack of parasitic resistance. MIC obtained in the LDA tests were 0.2144 µg/ ml for TBZ, 0.2792 µg/ml for PYR, 0.5429 µg/ml for MBZ, while ABZ came last (MIC = 0.8187 µg/ml). The in vitro tests proved the antiparasitic molecules efficacy against bisons nematode population and a limited risk of inducing resistance phenomena.
INTRODUCTION
Parasite invasions are one of the main diagnosed pathologies of European bison (Krzysiak et al., 2015) . If a poorly effective drug is used or if the efficient medication is underdosed, development of drug resistance occurs (Cernea et al., 2015 , Woodbury et al., 2011 . In order to be able to control these pathologies, it is important to monitor the dewormings and assess the effectiveness of the active ingredients used as antiparasitic medication (Cernea et al., 2005 , Demiaszkiewicz et al., 2010 , Krzysiak et al., 2015 . In this context, the present paper is aimed to evaluate the efficacy of benzimidazole and tetrahydropyrimidine anthelmintic agents against the intestinal nematodes of the European bison (Bison bonasus).
MATERIALS AND METHODS
An in vitro study was conducted to assess the efficacy of four anthelmintic drugs against in digestive strongylidosis in bison between October 2016 and May 2017. The ovicidal and larvicidal effects of benzimidazole derivatives, albendazole (ABZ), mebendazole (MBZ) and thiabendazole (TBZ) and larvicidal effect of pyrantel (PYR), a tetrahydropyrimidine derivative were evaluated. Jambre (1978) .
The total number of eggs per milliliter was determined applying the formula: Eggs/ml = (1000 x no. eggs per 50µl) / 50
Interpretation of EHA results was obtained by comparing them to the results obtained at a reference concentration of 0.15 mcg/ml, as strongyle populations in which eggs hatch in a percent of 50 or above are normally considered resistant. As initial solutions, serial dilutions from 500 mcg to 0.98 mcg active ingredient/ml were used. 2 ml well plates were used for conducting in vitro bioassays. In each of the first 10 wells, 790 μl of distilled water, 200 µl of egg suspension and 10 µl of each diluted drug solutions were placed, obtaining the final solutions, from 5.0 to 0.0098 mcg active ingredient/ml. Two controls were used, M 1 control consisted of 200 µl egg suspension and 800 µl distilled water and a the second one, M 2 , consisting of 790µl distilled water, 200 µl egg suspension and 10 µl of HCl solution. After 24 hours in the thermostat at 27ºC, samples were asessed by counting both the embryonated and unembryonated eggs as well as the hatched larvae.
The egg hatching percentage was determined applying the formula:
Egg hatching % = [(EE + L 1 ) / ( UE + EE + L 1 )] x 100
where EE represents the embryonated eggs, L 1 represents larvae L 1 and UE stands for unembryonated eggs (Coles et al., 1992 , Le Jambre et al, 1978 .
For Larval development assay (LDA), we tested the MIC after keeping the exogenous parasitic forms in contact with the antiparasitic medication for 14 days, at a constant temperature of 27ºC. Larval development percentage was calculated applying the formula:
where L 3 represents the number of L 3 larvae and UE stands for unembryonated eggs. 
RESULTS AND DISCUSSIONS
In EHA, for TBZ active ingredient, a substantial reduction of first stage larvae was observed, compared to the number of eggs, with 14500 eggs, respectively 4500 L 1 larvae. These were identified only in the case of 0.3125 mcg/ml dilution and in the control samples. The low hatching percentage determined, through statistical analysis, led to the calculation of a negative EC 50 , i.e. -0.2228 mcg/ml. To be able to get pharmacologically interpretable data with positive values of EC 50 , serial dilutions lower than 0.0098 mcg/ml should have been used. At the reference concentration (0.15 mcg/ ml), the hatching percentage was null by direct determination and, by mathematical analysis, we obtained a value of -8.7858 (Tab. 1).
For this molecule, the regression line had a negative trend, with an Y max of -773.34 mcg/ ml, prooving that the isolated bison parasite populations only possess a limited capacity to adapt to TBZ based medication.
EHA tests on albendazole showed different hatching percentages depending on the concentrations used. Twenty-four hours after incubation, the ratio between the total number of eggs and the total number of L 1 larvae, was 23500/6500.
Hatching percentage at the reference concentration was 33.33%, below the maximum allowed (50%). Mathematical analysis of the ABZ data showed a EC 50 of 0.3261 mcg/ml, the hatching percentage at the reference concentration being 33.81 mcg/ml (Tab. 1).
High values were also recorded at the parameters "a" and "b" which determined positive values for Y parameter, with a maximum of 479.19 mc/ml. As a result, the strongyle population has a high capacity to adapt in the future to ABZ-based anthelmintic products. It should be noted that in the case of ABZ, in vivo results may be very different from those obtained in vitro, due to its enterohepatic recirculation, which allows for the appearance of active metabolites that will repeatedly exercise their anthelmintic action. This phenomenon is known to be a drawback of the in vitro tests, compared to the in vivo faecal egg reduction test (Cernea et al., 2006) . As a result, it can be concluded that for albendazole EHA test results, highlight the ovocidal action.
The MBZ effect on strongyl eggs was highlighted by the fact that, 24 hours after incubation, a very small number of L 1 larvae (1100) was found compared to unhatched eggs (19000). At 0.0391 mcg/ml concentration, a hatching percentage of 9.09% was noticed, while for other dilutions the hatching percentage was null (Tab. 2).
In the control samples, the average hatching percentage was 50% which, by statistical analysis, determined a EC 50 of -0.2270 mcg/ml with a hatching percentage of -5.83%. As with TBZ, in order to obtain positive values for EC 50 , the serial dilutions should be higher than 5 mcg/ml.
The increased efficacy of MBZ is also proven by the regression line equation, whose Y max parameter was -860.66, being the lowest value of the tested benzimidazoles. For LDA test, in case of thiabendazole, the ratio between the total egg number + L 1 larvae + L 2 larvae to L 3 larvae, was 11500/7500, showing a different development percentage, depending on the used concentrations. At the maximum concentration of 5 mcg/ml, the development percentage was null, while at 2.5 mcg/ml the percentage was 75.
The maximum larval development percentage was recorded for 0.3125 mcg/ml concentration.
In control samples, average development percentage was 50% and, dependant on this value, mathematical analysis determined a minimum inhibitory concentration (MIC) of 0.2144 mcg/ml. Additionally, the value of the "a" parameter being a negative one (-148.36), allowed the calculation of the regression line equation, whose maximum Y parameter had the value of -707.48. Therefore, the efficacy of TBZ on this nematode population was also demonstrated by the LDA tests (Tab. 3). After 14 days of incubation, the total L 3 larvae number was 8000, compared to the other exogenous forms, which were 25000.
Tab
The first L 3 larvae identified were observed at 0.3125 mcg/ml dilution, the development percentage being 33%. Maximum rates of development were registered for 0.1563 mcg/ml, and 0.0098 mcg/ml dilutions. Mean development percentage on control samples was 25% and the mathematical calculations highlighted an albendazole MIC of 0.8187 mcg/ml. Regression line tendency was negative, with a value of the maximum Y parameter of -230.05 mcg/ml.
Results obtained by LDA when testing mebendazole showed that total number of infesting larvae was 6500, compared to other exogenous forms, which were 17500. At the maximum concentration (5 mcg/ml), development percentage was 33.33%.
The maximum development percentage (100%) was registered for 0.0781 mcg/ml concentration. In control samples, mean development percentage was 50%, determining for MBZ a MIC of 0.5429 mcg/ml. Regression line equation had a downward trend, maximum value of Y parameter being -276.47 mcg/ml (Tab. 4).
In the case of pyrantel (PYR), the larvicidal effect was proven by the fact that null values of larval developmental percentage were obtained at four different concentrations.
Also, a 25% larval development was calculated for 1.25 mcg/ml concentration and 100% larval development for 0.625 mcg/ml and 0.0098 mcg/ ml concentrations.
Mean larval development percentage for control samples was 50%. The first stage 3 larvae were identified at the 2.5 mcg/ml concentration, thus allowing, by global mathematical analysis, obtaining of a 0.2792 mcg/ml MIC. For PYR, regression line equation showed the maximum y parameter with the lowest value obtained in the LDA tests, respectively -767.12 mcg/ml. LDA tests showed that the minimal risk of inducing resistance to anthelmintic medication was registered for PYR (Y max = -767.12), followed by TBZ, MBZ and ABZ. From the EC 50 point of view, the maximum efficacy was recorded in MBZ and TBZ, the last being ABZ with a EC 50 of 0.326 mcg/ml. However, according to the standard interpretation of this test, in which the tested parasite population is considered to be resistant if the hatching percentage at the reference concentration (0.15 mcg/ml) is higher than 50% (Cernea et al., 2015; Coles et al., 1992) , all tested benzimidazoles have been shown to present hatching percentages as low as 50%. From this point of view, the best efficacy was recorded with MBZ, followed by TBZ and ABZ. Determination of MIC for the four tested anthelmintic substances, showed that the lower MIC was 0.2144 mcg/ml for TBZ, followed by PYR with 0.2792 mcg/ml, MBZ with 0.5429 mcg/ml, the last being ABZ with 0.8187 mcg/ml. As for the antiparasitic potency, TBZ and PYR had the best results, folowed by MBZ and ABZ.
The benzimidazole group efficacy results are similar to the ones obtained in other bison populations (Demiaszkiewicz et al., 2010) . The results show that bison strongyle populations are still very sensitive to benzimidazoles and tetrahydropyrimidines, totally diferent, compared to strongyle populations in horsers, which already developed a wide resistance against benzimidazoles, especially against ABZ (Cernea et al., 2015) .
CONCLUSIONS
Both in vitro tests showed efficacy of the evaluated antiparasitic active ingredients against strongyle population found in European bisons as well as a limited risk of inducing resistance phenomena.
It may be advisable to use MBZ-based products (EC 50 -0.2270) as antiparasitic medication against nematodes for this bison population, but subject to the fact that in vivo ABZ, due to its active metabolites, has a longer contact duration and efficacy than other benzimidazoles.
All benzimidazoles have been shown to have a hatching percentage much lower then 50%, reflecting a lack of resistance against this drug class for the tested strongyle population.
Even if tetrahydropyrimidines do not have ovicidal effects, they have shown a high antiparasitic potency, being a very good alternative in case of benzimidazole resistance.
